Pathophysiology of thrombotic thrombocytopenic purpura.
J. E. Sadler
semanticscholar +1 more source
The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec. [PDF]
Merlen C +8 more
europepmc +1 more source
Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics
M. Saha, Jenny K. McDaniel, X. Zheng
semanticscholar +1 more source
Association of Therapeutic Plasma Exchange-Treated Thrombotic Thrombocytopenic Purpura with Improved Mortality Outcome in End-Stage Renal Disease. [PDF]
Kincaid BS +5 more
europepmc +1 more source
Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura
T. Falter +10 more
semanticscholar +1 more source
New Insights Into Renal Involvement During Immune-Mediated Thrombotic Thrombocytopenic Purpura. [PDF]
Robert M +16 more
europepmc +1 more source
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.
E. E. Page +4 more
semanticscholar +1 more source
The Prognostic Value of Platelet Kinetics Assessment in Pediatric Chronic Idiopathic Thrombocytopenic Purpura. [PDF]
Igrutinovic N +17 more
europepmc +1 more source
Challenges in diagnosing thrombotic thrombocytopenic purpura. [PDF]
Jacobs JW, Booth GS, Adkins BD.
europepmc +1 more source

